KR970064596A - Hemorrhoid treatment composition for rectal administration - Google Patents
Hemorrhoid treatment composition for rectal administration Download PDFInfo
- Publication number
- KR970064596A KR970064596A KR1019960007638A KR19960007638A KR970064596A KR 970064596 A KR970064596 A KR 970064596A KR 1019960007638 A KR1019960007638 A KR 1019960007638A KR 19960007638 A KR19960007638 A KR 19960007638A KR 970064596 A KR970064596 A KR 970064596A
- Authority
- KR
- South Korea
- Prior art keywords
- rectal administration
- hemorrhoid
- hydrophilic natural
- composition
- therapeutic composition
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
본 발명은 치질치료제, 폴록사머 및 친수성 천연 고분자을 함유하는 직장투여용 치질치료제 조성물에 관한 것이다. 폴록사머와 친수성 천연 고분자를 함유하는 본 발명의 조성물은 상온에서는 액상이고 체내에서는 겔상인 새로운 직장투여용 치질치료제 조성물로서, 생산공정이 단순하기 때문에 제조가 용이하고 경제적이며 투여가 용이하고, 겔강도와 생체부착력이 우수하여 투여 후 체외로 빠져나오지 않으며 대장말단으로 이행되는 단점을 극복하여 계속적으로 약효를 발현할 때까지 직장에 머무를 수 있다.The present invention relates to a hemorrhoid therapeutic composition for rectal administration containing a hemorrhoid therapeutic agent, poloxamer and a hydrophilic natural polymer. The composition of the present invention comprising poloxamer and a hydrophilic natural polymer is liquid at room temperature and gel-like in the body. It is a novel hemorrhoid therapeutic composition for rectal administration. Since the production process is simple, it is easy to manufacture, And bioadhesive ability, it does not escape to the outside of the body after administration and overcomes the disadvantage that it is transferred to the end of the colon, so that it can stay in the work place until the efficacy is continuously exhibited.
폴록사머는 고상타입, 액상타입 및 페이스트 타입에서 선택된 1종 이상의 폴록사머가 조성물 총 함량의 25-40%로 함유되며, 친수성 천연 고분자는 키토산 및 알긴산 나트륨등의 천연 고분자가 총 함량의 0.1-1%로 함유된다.Poloxamers contain at least 25% to 40% of the total composition by weight of one or more poloxamers selected from the solid, liquid and paste types, and the hydrophilic natural polymers include natural polymers such as chitosan and sodium alginate, %.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is a trivial issue, I did not include the contents of the text.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960007638A KR970064596A (en) | 1996-03-21 | 1996-03-21 | Hemorrhoid treatment composition for rectal administration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960007638A KR970064596A (en) | 1996-03-21 | 1996-03-21 | Hemorrhoid treatment composition for rectal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970064596A true KR970064596A (en) | 1997-10-13 |
Family
ID=66215756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960007638A KR970064596A (en) | 1996-03-21 | 1996-03-21 | Hemorrhoid treatment composition for rectal administration |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR970064596A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020071407A (en) * | 2001-03-06 | 2002-09-12 | 최한곤 | Novel composite of liquid suppository for rectal administration |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
JPH05148159A (en) * | 1991-09-11 | 1993-06-15 | Euro Celtique Sa | Release control composition for medicine |
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
WO1994003157A1 (en) * | 1992-07-28 | 1994-02-17 | Poli Industria Chimica S.P.A. | Pharmaceutical compositions for transmucosal delivery of peptides |
US5292516A (en) * | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
US5346703A (en) * | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
-
1996
- 1996-03-21 KR KR1019960007638A patent/KR970064596A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
US5292516A (en) * | 1990-05-01 | 1994-03-08 | Mediventures, Inc. | Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers |
US5346703A (en) * | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
JPH05148159A (en) * | 1991-09-11 | 1993-06-15 | Euro Celtique Sa | Release control composition for medicine |
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
WO1994003157A1 (en) * | 1992-07-28 | 1994-02-17 | Poli Industria Chimica S.P.A. | Pharmaceutical compositions for transmucosal delivery of peptides |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020071407A (en) * | 2001-03-06 | 2002-09-12 | 최한곤 | Novel composite of liquid suppository for rectal administration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2362100B (en) | Wound gels | |
DE69803940D1 (en) | OPHTHALMIC COMPOSITION WITH EXTENDED RELEASE CONTAINING WATER-SOLUBLE MEDICINAL PRODUCTS | |
BR0114782A (en) | Copolymer composition, process for preparing same, aqueous composition, products, therapeutic agent-containing composition, electrolyte composition and use of the copolymer composition | |
BR9901782A (en) | Nefazodone dosage form. | |
HRP20010700B1 (en) | Pregelatinized starch in a controlled release formulation | |
WO1997005185A3 (en) | Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents | |
CA2136331A1 (en) | New pharmaceutical uses of krill enzymes | |
WO1999053897A3 (en) | Topical formulation comprising poloxamers and further microbicides, and an applicator | |
BR9916285A (en) | Process and composition to reduce the permeability of an underground area | |
BRPI0414017A (en) | multi-arm polymeric prodrugs | |
GR3033214T3 (en) | Cereal extracts. | |
BR9910531A (en) | Broad-spectrum microbicidal and spermicidal compositions, devices and methods | |
KR920009419A (en) | Miscible Blends Containing Chitosan | |
BR0308710A (en) | antimicrobial polymer conjugates | |
FR2542616B1 (en) | COMPOSITION FOR THE TREATMENT OF MUCOSA BASED ON AN ANTIBIOTIC AND A GEL-FORMING HYDROCOLLOID | |
EP0529931A3 (en) | Water modifier | |
CA2386406A1 (en) | Tissue products containing antiviral agents which are mild to the skin | |
KR970064596A (en) | Hemorrhoid treatment composition for rectal administration | |
DE60202590D1 (en) | 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS | |
BR9610211A (en) | Pharmaceutical compositions based on glyceryl poly (meta) acrylate gel | |
SE9403905D0 (en) | New formulations | |
ES2055680T1 (en) | FIXING PRODUCT AND PROCEDURE FOR PERMANENT HAIR MOLDING. | |
CA2384717A1 (en) | Topical treatment for prevention of ocular infections | |
CA2346631A1 (en) | Antibacterial aqueous ophthalmic formulations containing ofloxacin and use of chitosan for solubilizing ofloxacin suspended in an aqueous media | |
KR970061240A (en) | Composition for rectal administration of a drug which receives first-pass effect in the liver |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |